{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:25:43Z","timestamp":1761823543767,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"vor","delay-in-days":5185,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.7861\/clinmedicine.10-1-45","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T18:27:04Z","timestamp":1361298424000},"page":"45-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Primary hyperparathyroidism \u2013 is mild disease worth treating?"],"prefix":"10.1016","volume":"10","author":[{"given":"NJL","family":"Gittoes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MS","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.7861\/clinmedicine.10-1-45_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0002-9343(90)90346-F","article-title":"Nephrolithiasis and bone involvement in primary hyperparathyroidism","volume":"89","author":"Silverberg","year":"1990","journal-title":"Am J Med"},{"key":"10.7861\/clinmedicine.10-1-45_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00000658-200205000-00008","article-title":"Six hundred fifty-six consecutive explorations for primary hyperparathyroidism","volume":"235","author":"Udelsman","year":"2002","journal-title":"Ann Surg"},{"key":"10.7861\/clinmedicine.10-1-45_bib3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/jc.2008-1761","article-title":"Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Udelsman","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.10-1-45_bib4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/bmj.325.7368.807","article-title":"Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study","volume":"325","author":"Mollerup","year":"2002","journal-title":"BMJ"},{"key":"10.7861\/clinmedicine.10-1-45_bib5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","article-title":"Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism","volume":"321","author":"Vestergaard","year":"2000","journal-title":"BMJ"},{"key":"10.7861\/clinmedicine.10-1-45_bib6","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jc.2002-021370","article-title":"Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century","volume":"87","author":"Bilezikian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.10-1-45_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.10-1-45_bib8","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.10-1-45_bib9","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.10-1-45_bib11","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.10-1-45_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0002-9343(93)90260-V","article-title":"Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy","volume":"95","author":"Stefenelli","year":"1993","journal-title":"Am J Med"},{"key":"10.7861\/clinmedicine.10-1-45_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/BF01658740","article-title":"The influence of surgery on the risk of death in patients with primary hyperparathyroidism","volume":"15","author":"Hedback","year":"1991","journal-title":"World J Surg"},{"key":"10.7861\/clinmedicine.10-1-45_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","article-title":"Survival after the diagnosis of hyperparathyroidism: a population-based study","volume":"104","author":"Wermers","year":"1998","journal-title":"Am J Med"},{"key":"10.7861\/clinmedicine.10-1-45_bib15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2796.2002.00984.x","article-title":"Cardiovascular disease, hypertension and renal function in primary hyperparathyroidism","volume":"251","author":"Hedback","year":"2002","journal-title":"J Intern Med"},{"key":"10.7861\/clinmedicine.10-1-45_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2796.1991.tb00403.x","article-title":"Cardiovascular risk factors in primary hyperparathyroidism: a 15-year follow-up of operated and unoperated cases","volume":"230","author":"Lind","year":"1991","journal-title":"J Intern Med"},{"key":"10.7861\/clinmedicine.10-1-45_bib17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0895-4356(97)00104-2","article-title":"Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years","volume":"50","author":"Lind","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.7861\/clinmedicine.10-1-45_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.hjr.0000114706.27531.01","article-title":"Serum parathyroid hormone levels predict coronary heart disease: the Tromso Study","volume":"11","author":"Kamycheva","year":"2004","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.7861\/clinmedicine.10-1-45_bib19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.surg.2005.02.001","article-title":"Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism","volume":"137","author":"Nilsson","year":"2005","journal-title":"Surgery"},{"key":"10.7861\/clinmedicine.10-1-45_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.1999.00651.x","article-title":"Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy","volume":"50","author":"Piovesan","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.7861\/clinmedicine.10-1-45_bib21","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1067\/msy.2002.128692","article-title":"Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy","volume":"132","author":"Almqvist","year":"2002","journal-title":"Surgery"},{"key":"10.7861\/clinmedicine.10-1-45_bib22","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1067\/msy.2000.110240","article-title":"Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy","volume":"128","author":"Nilsson","year":"2000","journal-title":"Surgery"},{"key":"10.7861\/clinmedicine.10-1-45_bib23","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/jc.2004-1400","article-title":"Arterial stiffness in mild primary hyperparathyroidism","volume":"90","author":"Rubin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.10-1-45_bib24","first-page":"401","article-title":"Occurrence of pituitary adenomas and other neoplastic diseases in primary hyperparathyroidism","volume":"151","author":"Wajngot","year":"1980","journal-title":"Surg Gynecol Obstet"},{"key":"10.7861\/clinmedicine.10-1-45_bib25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0002-9610(73)80046-7","article-title":"Primary hyperparathyroidism and cancer","volume":"126","author":"Farr","year":"1973","journal-title":"Am J Surg"},{"key":"10.7861\/clinmedicine.10-1-45_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1359\/jbmr.2001.16.1.113","article-title":"Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism","volume":"16","author":"Rossini","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.7861\/clinmedicine.10-1-45_bib28","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial","volume":"89","author":"Khan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.10-1-45_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF01623394","article-title":"Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report","volume":"6","author":"Diamond","year":"1996","journal-title":"Osteoporos Int"},{"key":"10.7861\/clinmedicine.10-1-45_bib30","first-page":"3487","article-title":"Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"81","author":"Guo","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.10-1-45_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.10-1-45_bib32","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.7861\/clinmedicine.10-1-45_bib33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jc.2008-1762","article-title":"Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Khan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.10-1-45_bib34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1530\/eje.1.02029","article-title":"Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis","volume":"153","author":"Sejean","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.7861\/clinmedicine.10-1-45_bib36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.surg.2008.03.044","article-title":"How should age at diagnosis impact treatment strategy in asymptomatic primary hyperparathyroidism? A cost-effectiveness analysis","volume":"144","author":"Zanocco","year":"2008","journal-title":"Surgery"},{"key":"10.7861\/clinmedicine.10-1-45_bib10","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.10-1-45_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","article-title":"Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Chow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.10-1-45_bib35","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.surg.2006.07.032","article-title":"Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroidism","volume":"140","author":"Zanocco","year":"2006","journal-title":"Surgery"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824051133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824051133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmedicine.10-1-45","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:41:45Z","timestamp":1761460905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824051133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1470211824051133"],"URL":"https:\/\/doi.org\/10.7861\/clinmedicine.10-1-45","relation":{},"ISSN":["1470-2118"],"issn-type":[{"type":"print","value":"1470-2118"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary hyperparathyroidism \u2013 is mild disease worth treating?","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmedicine.10-1-45","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2010. All rights reserved.","name":"copyright","label":"Copyright"}]}}